Low-dose irradiation inhibits proliferation of the p53null type human prostate cancer cells through the ATM/p21 pathway
Sijie Li(Tsinghua–Berkeley Shenzhen Institute), Jiuwei Cui(Jilin University)
Cited by 14
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
|Biomarker Research|2020|473
Mechanisms of Cancer Resistance to Immunotherapy
|Frontiers in Oncology|2020|346
An overview of graphene-based hydroxyapatite composites for orthopedic applications
|Bioactive Materials|2018|240